Literature DB >> 10068811

MRI in vitamin B12 deficiency myelopathy.

E R Locatelli1, R Laureno, P Ballard, A S Mark.   

Abstract

BACKGROUND: Little is known about vitamin B12 deficiency myelopathy's magnetic resonance imaging (MRI) manifestations and their relationship to the onset, evolution, and resolution of neurologic signs and symptoms.
METHODS: We present a case and review eleven additional reported cases of subacute combined degeneration of the spinal cord detected by MRI.
RESULTS: Our patient had increased T2-weighted signal and gadolinium contrast enhancement of the posterior columns in the cervical and thoracic regions and enhancement of the lateral columns in the high cervical region. This is a case with imaging evidence for lateral column lesions. Two prior reports have shown posterior column enhancement. T1-weighted images may show decreased signal in the posterior columns and sometimes demonstrate reversible spinal cord swelling. MRI abnormalities typically improve after vitamin replacement therapy. However, clinical signs may persist despite resolution of imaging abnormalities, and these abnormalities do not always resolve completely. In addition, symptoms may precede the imaging abnormality.
CONCLUSIONS: Vitamin B12 deficiency may produce an increased T2-weighted signal, decreased T1-weighted signal, and contrast enhancement of the posterior and lateral columns of the spinal cord, mainly of the cervical and upper thoracic segments. Because the symptoms may precede any imaging abnormality, it is clear that spinal cord MRI may not be a highly sensitive, early test for subacute combined degeneration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068811

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  9 in total

Review 1.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

Review 2.  Myelopathy.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-05       Impact factor: 3.825

3.  Clinical and MRI manifestations of nitrous oxide induced vitamin B12 deficiency: A case report.

Authors:  Anahid Safari; Farhad Emadi; Elham Jamali; Afshin Borhani-Haghighi
Journal:  Iran J Neurol       Date:  2013

4.  Imaging features of copper deficiency myelopathy: a study of 25 cases.

Authors:  Neeraj Kumar; J Eric Ahlskog; Christopher J Klein; John D Port
Journal:  Neuroradiology       Date:  2005-10-28       Impact factor: 2.804

5.  Early treatment causes clinicoradiological reversal of myelopathy due to vitamin B12 deficiency.

Authors:  Rajesh Verma; Prakash Kori; Tushar B Patil; Heramba Narayan Praharaj
Journal:  BMJ Case Rep       Date:  2013-05-27

6.  Spinal MR imaging in Vitamin B12 deficiency: Case series; differential diagnosis of symmetrical posterior spinal cord lesions.

Authors:  Anitha Sen; Kesavadas Chandrasekhar
Journal:  Ann Indian Acad Neurol       Date:  2013-04       Impact factor: 1.383

7.  Ataxic gait following total gastrectomy for gastric cancer.

Authors:  Chang Ho Hwang; Dong Jin Park; Gyu Yeol Kim
Journal:  World J Gastroenterol       Date:  2016-10-07       Impact factor: 5.742

8.  Reversible cutaneous silent period abnormalities in vitamin B12 deficiency: A case report.

Authors:  Elena Fava; Markus Kofler; Leopold Saltuari
Journal:  Clin Neurophysiol Pract       Date:  2019-05-31

9.  Serum Vitamin B12, Homocysteine and Methylmalonic Acid Levels in Patients With Parenchymal Neuro-Behçet's Syndrome.

Authors:  Berivan Bitik; Abdurrahman Tufan; Şehri Elbeg; Rıdvan Mercan; Hamit Küçük; Orhan Küçükşahin; Mehmet Akif Öztürk; Seminur Haznedaroğlu; Berna Göker
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.